Systematic reviews and meta-analyses exist for several mushroom health topics, including turkey tail (Coriolus versicolor) alongside chemotherapy, reishi (Ganoderma lucidum) as a cancer adjunct, lion’s mane (Hericium erinaceus) for cognition and mood, and cordyceps for exercise performance. None of these reviews establish that a mushroom supplement treats or cures a disease. Most describe modest, uncertain, or preliminary effects and call for better-designed trials.
This guide lists the systematic reviews that actually exist, explains why this type of study carries more weight than a single trial, and shows the limitations reviewers themselves flagged. Use it as a starting point, not a final verdict, on any specific health claim.
Important Safety Note Before You Read Further
Several of the reviews below involve people undergoing cancer treatment. Mushroom extracts, including reishi and turkey tail, can affect immune activity and, in some formulations, blood clotting. Anyone on chemotherapy, radiotherapy, immunosuppressant medication, or blood thinners, or anyone scheduled for surgery, should talk with their treating clinician before adding any mushroom supplement. This article is educational. It is not medical advice, and it does not recommend starting, stopping, or changing any treatment.
Why a Systematic Review Carries More Weight Than One Study
A single study can be small, poorly controlled, or a statistical outlier. A systematic review searches the published literature using a defined method, applies set criteria to decide which studies count, and then summarizes what those studies found together. A meta-analysis goes a step further and pools the numbers from multiple trials into one combined estimate.
This matters because one promising trial can look convincing on its own but fail to replicate. A systematic review shows whether an effect holds up across multiple research groups, populations, and designs, or whether it was a one-off result. The National Library of Medicine’s PubMed database is the standard place researchers search to build these reviews, and the Cochrane Library is widely regarded as producing the most rigorous version of this process for medical questions.
Systematic Reviews That Exist, By Topic
Turkey Tail (Coriolus versicolor / PSK) and Chemotherapy Support
A 2022 Cochrane review looked at Coriolus versicolor mushroom extract (polysaccharide-K, or PSK) added to chemotherapy or radiotherapy for colorectal cancer. It included seven randomized trials with 1,569 participants, mostly from Japan and China. The review found low-certainty evidence of a small survival benefit at five years, meaning roughly 1 in 16 patients might benefit, but the certainty was low and effects at earlier time points were unclear. The reviewers said they were uncertain about PSK’s effect on treatment-related side effects like nausea, diarrhea, and low white blood cell counts because the evidence was very low certainty.
Separately, the National Cancer Institute’s clinician-facing summary describes a larger body of PSK research in gastric cancer: a pooled analysis of over 8,000 patients from randomized trials found that adding PSK to chemotherapy modestly improved overall survival compared with chemotherapy alone. A pooled analysis of three colorectal cancer trials covering about 1,094 patients found a similar pattern. These are the strongest human data behind any mushroom-cancer question, and they still describe PSK as an adjunct alongside standard treatment, not a replacement for it.
Reishi (Ganoderma lucidum) as a Cancer Adjunct
A Cochrane review of Ganoderma lucidum for cancer treatment included five randomized trials with 373 participants, all from Chinese populations. When reishi was combined with chemotherapy or radiotherapy, patients were more likely to show a positive tumor response than with chemo or radiotherapy alone, though reishi by itself did not meaningfully shrink tumors. No trial in the review tracked long-term survival, so the reviewers could not say whether reishi extends life. Immune markers such as CD3, CD4, and CD8 lymphocyte counts increased with reishi, though natural killer cell activity improved only slightly. Quality-of-life scores were somewhat better in the reishi group, and side effects were generally mild, mainly nausea and insomnia. The reviewers concluded reishi could be considered an adjunct to conventional treatment, not a primary therapy, and called for larger, better-designed trials.
The National Cancer Institute’s summary adds that most reishi research measures immune markers rather than actual cancer outcomes, and results on immune function are mixed. One trial of a different reishi extract found fewer colon polyps developed in a treated group over 12 months compared with controls, but this is one prevention trial, not a treatment trial, and has not been broadly replicated.
Lion’s Mane (Hericium erinaceus) for Cognition and Mood
Lion’s mane has a recent systematic review of its benefits, side effects, and uses as a supplement, and a separate review examining mushrooms broadly, including lion’s mane, for mood and neurocognitive health across the lifespan. Both describe human trials as still limited: small sample sizes, short durations, and inconsistent dosing across studies. Some individual trials report improvements in mild cognitive symptoms or mood measures in older adults, but a systematic review’s job is to look at the pattern across trials, and the current pattern is described as preliminary rather than established. Reviewers consistently note that most of the mechanistic groundwork explaining how lion’s mane might affect nerve growth factor comes from cell and animal research, not human trials.
Cordyceps for Exercise Performance
A systematic review of randomized controlled trials on Ophiocordyceps sinensis (cordyceps) supplementation in healthy humans, along with a broader systematic review and meta-analysis of fungal supplements in adult athletes, found inconsistent results across endurance, oxygen uptake, and recovery markers. Some individual trials report modest benefits; others find no measurable difference from placebo. The reviewers describe the evidence as too limited and heterogeneous, in terms of dose, extract type, and training population, to draw a firm conclusion either way.
Evidence Summary
- Turkey tail (PSK) plus chemotherapy, colorectal cancer: Cochrane systematic review of 7 randomized trials, 1,569 participants. Small survival benefit at 5 years; uncertain effect on side effects. Certainty: low to very low.
- Turkey tail (PSK) plus chemotherapy, gastric cancer: Pooled analysis cited in the NCI clinician summary, 8,009 participants. Modest improvement in overall survival when added to chemotherapy.
- Reishi plus chemotherapy or radiotherapy: Cochrane systematic review of 5 randomized trials, 373 participants. Better tumor response as an adjunct; survival not measured; quality of life somewhat improved. Certainty: low, small single-country trials.
- Lion’s mane for cognition and mood: Systematic reviews of small human trials with short durations. Preliminary signals only; most mechanism data come from animal and cell studies.
- Cordyceps for exercise performance: Systematic reviews and a meta-analysis covering multiple small randomized trials in athletes and healthy adults. Results are inconsistent across studies.
Limitations Reviewers Flagged Again and Again
Reading across these reviews, the same limitations show up repeatedly.
Small, geographically narrow samples. The reishi cancer review drew entirely on Chinese trial populations. The turkey tail review drew mainly on Japanese and Chinese populations. Findings from one country’s patient population, treatment protocols, and mushroom extract source do not automatically apply to a different population using a different product.
Inconsistent products and doses. “Reishi” or “lion’s mane” in one trial may be a different extract, concentration, or preparation than in another. Reviewers cannot pool results cleanly when the tested product varies this much, which is a core reason certainty ratings stay low.
Short trial duration. Many trials run for weeks to a few months. Few track outcomes like long-term survival or lasting cognitive change.
Outdated treatment regimens. The Cochrane turkey tail reviewers specifically noted that some included trials used chemotherapy regimens that are no longer standard practice, which limits how well the results apply to current cancer care.
Missing survival and hard outcome data. The reishi review found no trial that tracked long-term survival at all, so a key question many readers care about most remains unanswered by the existing evidence.
Publication and reporting bias. Systematic reviewers routinely note that studies with positive results are more likely to get published, which can make the overall evidence picture look stronger than it is.
How to Use a Systematic Review When Evaluating a Claim
- Find out if a systematic review or Cochrane review exists for the specific mushroom, form, and outcome you’re checking, not just the mushroom in general.
- Check how many human trials and participants were included. A review built on 5 small trials carries less weight than one built on dozens.
- Look for the certainty rating the reviewers assigned (high, moderate, low, or very low). Low-certainty findings can still be true, but they should be held loosely.
- Check whether the mushroom was tested alone or as an adjunct alongside standard treatment. Most reviews above tested mushrooms added to conventional care, not as a replacement.
- Read the limitations section of the review itself. Reviewers are usually the most honest source about what their own review cannot tell you.
For a deeper walkthrough of this process, see our guide to reading a mushroom clinical trial and our evidence hierarchy guide, which explains how cell, animal, and human studies rank against each other.
Groups Who Need Extra Caution
The topics with the most systematic review data involve cancer treatment, which means the safety stakes are higher than for a general wellness supplement. Extra caution applies to people currently on chemotherapy or radiotherapy, people taking immunosuppressant medication (including after organ transplant), people on blood-thinning medication, people scheduled for surgery, pregnant or breastfeeding people, and anyone with a diagnosed autoimmune condition. None of the reviews above support self-directed use of mushroom extracts to treat cancer or replace prescribed treatment. Every review that found a benefit tested the mushroom extract added to standard medical care under clinical supervision, not used on its own.
For a full breakdown of interaction risks by mushroom species, see our safety and interactions guide.
Frequently Asked Questions
Is there a systematic review proving mushrooms cure cancer?
No. The systematic reviews on reishi and turkey tail examine these extracts as an addition to standard chemotherapy or radiotherapy, not as a standalone cure. The strongest data, on turkey tail’s PSK extract in gastric and colorectal cancer, show a modest survival improvement when added to chemotherapy, not a replacement for it.
Why do different mushroom reviews reach different certainty levels?
Certainty depends on how many human trials exist, how large and well-designed they are, and how consistent their results are. Turkey tail and reishi have Cochrane reviews built on multiple randomized trials, which is more evidence than most other mushroom species currently have. Lion’s mane and cordyceps reviews describe fewer, smaller, and more inconsistent human trials, which keeps their certainty lower.
Does a low-certainty rating mean the finding is false?
No. Low certainty means researchers are less confident the measured effect reflects the true effect, often because of small sample sizes or study design limits. It does not mean the finding is wrong, only that more and better research is needed before treating it as settled.
Where can I check if a systematic review exists for a specific mushroom claim?
Search PubMed directly and add “systematic review” or “meta-analysis” to your search terms, or check the Cochrane Library for a formal Cochrane review. Our evidence grading and source policy page explains how we rank source types when a systematic review isn’t available.
Educational Disclaimer
This article is for general education about published research. It is not medical advice and does not diagnose, treat, cure, or prevent any disease. It does not recommend starting, stopping, or changing any medication or treatment. Talk with a qualified healthcare provider before using any mushroom supplement, especially if you are undergoing cancer treatment, take immunosuppressant or blood-thinning medication, are pregnant or breastfeeding, or have a chronic health condition.